Return to homepagePandemic Pact

Targeting the Complement system - alveolar epithelial response to COVID-19 with Mirococept

  • Funded by British Society for Antimicrobial Chemotherapy (BSAC)
  • Total publications:1 publications

Grant number: BSAC-COVID-57

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Known Financial Commitments (USD)

    $69,300

  • Funder

    British Society for Antimicrobial Chemotherapy (BSAC)

  • Principal Investigator

    Steven Sacks, Linda Klavinskis, Anastasia   Polycarpou

  • Research Location

    United Kingdom

  • Lead Research Institution

    Guy's Hospital

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Disease pathogenesis

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

1 Publication linked via Europe PMC

Last Updated:4 days ago

View all publications at Europe PMC

Glycan recognition by collectin-11 drives SARS-CoV-2 infectivity and membrane injury of respiratory epithelial cells.